Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Identifying key elements to inform HIV-testing interventions for primary care in Belgium.

Apers H, Nöstlinger C, Van Beckhoven D, Deblonde J, Apers L, Verheyen K, Loos J; HERMETIC Study Group .

Health Promot Int. 2019 May 5. pii: daz037. doi: 10.1093/heapro/daz037. [Epub ahead of print]

PMID:
31056680
2.

Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation study.

Tadesse M, Abebe G, Bekele A, Bezabih M, Yilma D, Apers L, de Jong BC, Rigouts L.

Clin Microbiol Infect. 2019 Aug;25(8):1000-1005. doi: 10.1016/j.cmi.2018.12.018. Epub 2018 Dec 22.

PMID:
30583052
3.

Lymphogranuloma venereum is on the rise in Belgium among HIV negative men who have sex with men: surveillance data from 2011 until the end of June 2017.

De Baetselier I, Tsoumanis A, Verbrugge R, De Deken B, Smet H, Abdellati S, Cuylaerts V, Apers L, Crucitti T.

BMC Infect Dis. 2018 Dec 20;18(1):689. doi: 10.1186/s12879-018-3600-0.

4.

A study of outpatient healthcare use by ageing people with HIV.

Geys M, Remmen R, Apers L.

Acta Clin Belg. 2019 Jun;74(3):189-193. doi: 10.1080/17843286.2018.1480453. Epub 2018 Jul 20.

PMID:
30029589
5.

Repeat Syphilis Is More Likely to Be Asymptomatic in HIV-Infected Individuals: A Retrospective Cohort Analysis With Important Implications for Screening.

Kenyon C, Osbak KK, Apers L.

Open Forum Infect Dis. 2018 Apr 28;5(6):ofy096. doi: 10.1093/ofid/ofy096. eCollection 2018 Jun.

6.

PrEP from a clinician's perspective.

Apers L, Platteau T, Caluwaerts S.

Acta Clin Belg. 2018 Apr;73(2):165-166. doi: 10.1080/17843286.2017.1394509. No abstract available.

PMID:
29560820
7.

Lymphogranuloma venereum among patients presenting at the HIV/STI clinic in Antwerp, Belgium : a case series.

Apers L, Florence E, Crucitti T, Anwar N.

Acta Gastroenterol Belg. 2017 Jul-Sep;80(3):385-387.

PMID:
29560668
8.

HIV testing for key populations in Europe: A decade of technological innovation and patient empowerment complement the role of health care professionals.

Platteau T, van Lankveld J, Apers L, Fransen K, Rockstroh J, Florence E.

HIV Med. 2018 Feb;19 Suppl 1:71-76. doi: 10.1111/hiv.12601.

PMID:
29488698
9.

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.

Smit GS, Apers L, Arrazola de Onate W, Beutels P, Dorny P, Forier AM, Janssens K, Macq J, Mak R, Schol S, Wildemeersch D, Speybroeck N, Devleesschauwer B.

Bull World Health Organ. 2017 Jan 1;95(1):27-35. doi: 10.2471/BLT.16.169383. Epub 2016 Nov 3.

10.

GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings.

Tadesse M, Abebe G, Abdissa K, Aragaw D, Abdella K, Bekele A, Bezabih M, Apers L, de Jong BC, Rigouts L.

PLoS One. 2015 Sep 14;10(9):e0137471. doi: 10.1371/journal.pone.0137471. eCollection 2015.

11.

Swab2know: An HIV-Testing Strategy Using Oral Fluid Samples and Online Communication of Test Results for Men Who Have Sex With Men in Belgium.

Platteau T, Fransen K, Apers L, Kenyon C, Albers L, Vermoesen T, Loos J, Florence E.

J Med Internet Res. 2015 Sep 1;17(9):e213. doi: 10.2196/jmir.4384.

12.

Risk factors for HCV acquisition among HIV-positive MSM in Belgium.

Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J, Kenyon C, Florence E, Buvé A.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):585-93. doi: 10.1097/QAI.0000000000000528.

PMID:
25763786
13.

Bacteriological methods as add on tests to fine-needle aspiration cytology in diagnosis of tuberculous lymphadenitis: can they reduce the diagnostic dilemma?

Abdissa K, Tadesse M, Bezabih M, Bekele A, Apers L, Rigouts L, Abebe G.

BMC Infect Dis. 2014 Dec 31;14:720. doi: 10.1186/s12879-014-0720-z.

14.

Syphilis reinfections pose problems for syphilis diagnosis in Antwerp, Belgium - 1992 to 2012.

Kenyon C, Lynen L, Florence E, Caluwaerts S, Vandenbruaene M, Apers L, Soentjens P, Van Esbroeck M, Bottieau E.

Euro Surveill. 2014 Nov 13;19(45):20958.

15.

Concentration of lymph node aspirate improves the sensitivity of acid fast smear microscopy for the diagnosis of tuberculous lymphadenitis in Jimma, southwest Ethiopia.

Tadesse M, Abebe G, Abdissa K, Bekele A, Bezabih M, Apers L, Colebunders R, Rigouts L.

PLoS One. 2014 Sep 3;9(9):e106726. doi: 10.1371/journal.pone.0106726. eCollection 2014.

16.

Incidence of HCV and sexually transmitted diseases among hiv positive msm in antwerp, belgium, 2001-2011.

Apers L, Koole O, Bottieau E, Vandenbruaene M, Ophoff D, Van Esbroeck M, Crucitti T, Florence E.

Acta Clin Belg. 2013 Nov-Dec;68(6):421-6. doi: 10.2143/ACB.3315.

PMID:
24635329
17.

Patients' satisfaction with sexual and reproductive health services delivered in HIV clinics across European regions.

Platteau T, Müller MC, Nideröst S, Csepe P, Dedes N, Apers L, Schrooten W, Nöstlinger C; Eurosupport 5 Study Group.

Cent Eur J Public Health. 2013 Sep;21(3):123-7.

18.

Evaluation of the 2007 WHO guideline to diagnose smear negative tuberculosis in an urban hospital in Ethiopia.

Abebe G, Deribew A, Apers L, Abdissa A, Kiflie Y, Koole O, Colebunders R.

BMC Infect Dis. 2013 Sep 11;13:427. doi: 10.1186/1471-2334-13-427.

19.

Erectile dysfunction, testosterone deficiency, and risk of coronary heart disease in a cohort of men living with HIV in Belgium.

De Ryck I, Van Laeken D, Apers L, Colebunders R.

J Sex Med. 2013 Jul;10(7):1816-22. doi: 10.1111/jsm.12175. Epub 2013 May 7.

PMID:
23651241
20.

Female Genital Cutting and Hepatitis C Spread in Egypt.

Kenyon C, Buyze J, Apers L, Colebunders R.

ISRN Hepatol. 2013 May 7;2013:617480. doi: 10.1155/2013/617480. eCollection 2013.

21.

Voluntary outreach counselling and testing for HIV and STI among men who have sex with men in Antwerp.

Platteau T, Wouters K, Apers L, Avonts D, Nöstlinger C, Sergeant M, Florence E.

Acta Clin Belg. 2012 May-Jun;67(3):172-6.

PMID:
22897064
22.

Sexually transmitted infections: what's new?

Apers L, Crucitti T, Verbrugge R, Vandenbruaene M.

Acta Clin Belg. 2012 May-Jun;67(3):154-9. Review.

PMID:
22897062
23.

Tuberculosis lymphadenitis in Southwest Ethiopia: a community based cross-sectional study.

Abebe G, Deribew A, Apers L, Abdissa A, Deribie F, Woldemichael K, Shiffa J, Tesfaye M, Jira C, Bezabih M, Aseffa A, Bekele A, Colebunders R.

BMC Public Health. 2012 Jul 6;12:504. doi: 10.1186/1471-2458-12-504.

24.

Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.

Abebe G, Abdissa K, Abdissa A, Apers L, Agonafir M, de-Jong BC, Colebunders R.

BMC Res Notes. 2012 May 10;5:225. doi: 10.1186/1756-0500-5-225.

25.

Prevalence of pulmonary TB and spoligotype pattern of Mycobacterium tuberculosis among TB suspects in a rural community in Southwest Ethiopia.

Deribew A, Abebe G, Apers L, Abdissa A, Deribe F, Woldemichael K, Jira C, Tesfaye M, Shiffa J, Aseffa A, Bezabih M, Abeje T, Colebunders R.

BMC Infect Dis. 2012 Mar 13;12:54. doi: 10.1186/1471-2334-12-54.

26.

Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults.

Koole O, Thai S, Khun KE, Pe R, van Griensven J, Apers L, Van den Ende J, Mao TE, Lynen L.

PLoS One. 2011 Apr 6;6(4):e18502. doi: 10.1371/journal.pone.0018502.

27.

The Use of Interferon-γ Release Assays for Tuberculosis Screening in International Travelers.

Apers L, Yansouni C, Soentjens P, Vekemans M, Bottieau E.

Curr Infect Dis Rep. 2011 Jun;13(3):229-35. doi: 10.1007/s11908-011-0173-0.

PMID:
21312007
28.

Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings.

Abebe G, Paasch F, Apers L, Rigouts L, Colebunders R.

J Microbiol Methods. 2011 Feb;84(2):155-60. doi: 10.1016/j.mimet.2010.11.014. Epub 2010 Dec 1. Review.

PMID:
21129417
29.

Knowledge, health seeking behavior and perceived stigma towards tuberculosis among tuberculosis suspects in a rural community in southwest Ethiopia.

Abebe G, Deribew A, Apers L, Woldemichael K, Shiffa J, Tesfaye M, Abdissa A, Deribie F, Jira C, Bezabih M, Aseffa A, Duchateau L, Colebunders R.

PLoS One. 2010 Oct 11;5(10):e13339. doi: 10.1371/journal.pone.0013339.

30.

Uptake of provider-initiated counselling and testing among tuberculosis suspects, Ethiopia.

Deribew A, Negussu N, Kassahun W, Apers L, Colebunders R.

Int J Tuberc Lung Dis. 2010 Nov;14(11):1442-6.

PMID:
20937185
31.

Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009.

Bottieau E, Apers L, Van Esbroeck M, Vandenbruaene M, Florence E.

Euro Surveill. 2010 Sep 30;15(39):19673.

32.

Common mental disorders in TB/HIV co-infected patients in Ethiopia.

Deribew A, Tesfaye M, Hailmichael Y, Apers L, Abebe G, Duchateau L, Colebunders R.

BMC Infect Dis. 2010 Jul 9;10:201. doi: 10.1186/1471-2334-10-201.

33.

Prejudice and misconceptions about tuberculosis and HIV in rural and urban communities in Ethiopia: a challenge for the TB/HIV control program.

Deribew A, Abebe G, Apers L, Jira C, Tesfaye M, Shifa J, Abdisa A, Woldemichael K, Deribie F, Bezabih M, Aseffa A, Colebunders R.

BMC Public Health. 2010 Jul 6;10:400. doi: 10.1186/1471-2458-10-400.

34.

Tuberculosis and HIV co-infection: its impact on quality of life.

Deribew A, Tesfaye M, Hailmichael Y, Negussu N, Daba S, Wogi A, Belachew T, Apers L, Colebunders R.

Health Qual Life Outcomes. 2009 Dec 29;7:105. doi: 10.1186/1477-7525-7-105.

35.

Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other.

Colebunders R, Worodria W, Jones-López E, Joloba M, Apers L, Ellner J.

Trop Med Int Health. 2008 Sep;13(9):1204-7. doi: 10.1111/j.1365-3156.2008.02127.x. Epub 2008 Jul 28.

36.

Geographical distribution of pulmonary tuberculosis cases notified during one year in Gweru, Zimbabwe.

Apers LM, Chimusoro A, Chihota V.

Cent Afr J Med. 2005 May-Jun;51(5-6):62-4. No abstract available.

PMID:
17432434
37.

Predominance of a single genotype of Mycobacterium tuberculosis in regions of Southern Africa.

Chihota V, Apers L, Mungofa S, Kasongo W, Nyoni IM, Tembwe R, Mbulo G, Tembo M, Streicher EM, van der Spuy GD, Victor TC, van Helden P, Warren RM.

Int J Tuberc Lung Dis. 2007 Mar;11(3):311-8.

PMID:
17352098
38.

Tuberculosis in resource poor countries.

Colebunders R, Apers L, Dieltiens G, Worodria W.

BMJ. 2007 Jan 20;334(7585):105-6. No abstract available.

39.

Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.

Van den Bosch GA, Van Gulck E, Ponsaerts P, Nijs G, Lenjou M, Apers L, Kint I, Heyndrickx L, Vanham G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF.

J Immunother. 2006 Sep-Oct;29(5):512-23.

PMID:
16971807
40.

Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.

Apers L, Lynen L, Worodria W, Colebunders R.

Trop Med Int Health. 2005 Dec;10(12):1209-14. Review.

41.

Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV prevalence.

Apers L, Wijarajah C, Mutsvangwa J, Chigara N, Mason P, van der Stuyft P.

Int J Tuberc Lung Dis. 2004 Aug;8(8):945-51.

PMID:
15305475
42.

Susceptibility of a series of routine sputum samples for antituberculosis chemotherapy in Gweru, Zimbabwe.

Apers LM, Chihota V.

S Afr Med J. 2004 Apr;94(4):282. No abstract available.

43.

Treatment of multidrug-resistant tuberculosis.

Colebunders R, Apers L, Shamputa IC.

Lancet. 2004 Apr 10;363(9416):1240. No abstract available.

PMID:
15081672
44.

Clinical and biomedical aspects of gonorrhoea, diagnosed in symptomatic patients in Midlands Province, Zimbabwe.

Apers L, Zishiri C.

Cent Afr J Med. 2002 Jul-Aug;48(7-8):94-5. No abstract available.

PMID:
14562528
45.

A comparison of direct microscopy, the concentration method and the Mycobacteria Growth Indicator Tube for the examination of sputum for acid-fast bacilli.

Apers L, Mutsvangwa J, Magwenzi J, Chigara N, Butterworth A, Mason P, Van der Stuyft P.

Int J Tuberc Lung Dis. 2003 Apr;7(4):376-81.

PMID:
12729344
46.

Caesarean section rate as a process indicator of safe motherhood programmes: the case of Midlands Province.

Zezai A, Apers L, Zishiri C.

Cent Afr J Med. 2001 May;47(5):129-34.

PMID:
11921671
47.

Trends in caesarean section rates at a maternity hospital in Mumbai, India.

Mehta A, Apers L, Verstraelen H, Temmerman M.

J Health Popul Nutr. 2001 Dec;19(4):306-12.

PMID:
11855353
48.

Rate of caesarean section as a process indicator of safe-motherhood programmes: the case of Kenya.

Gichangi P, Apers L, Temmerman M.

J Health Popul Nutr. 2001 Jun;19(2):52-8.

PMID:
11503347
49.

Effect of a syphilis control programme on pregnancy outcome in Nairobi, Kenya.

Temmerman M, Gichangi P, Fonck K, Apers L, Claeys P, Van Renterghem L, Kiragu D, Karanja G, Ndinya-Achola J, Bwayo J.

Sex Transm Infect. 2000 Apr;76(2):117-21.

50.

Maternal mortality: the figures--value and validity.

Apers LM.

Trop Doct. 2000 Apr;30(2):88-91. Review. No abstract available.

PMID:
10842554

Supplemental Content

Support Center